They also found that FAT1 is expressed at lower levels in early-stage FSHD-affected muscles compared to later-stage or unaffected muscles in control fetal human biopsies or developing mice embryos [65]. This evidence concerns the gene FAT1 and facioscapulohumeral muscular dystrophy.